Dr. Scott Rocklage has been described as a revolutionary in the field of medicine. He is currently a managing partner at 5AM Ventures and an authoritative figure in the industry.
Dr. Scott attended the University of California, Berkley where he earned his Bachelor of Science degree in Chemistry. He went on to further his education at the Massachusetts Institute of Technology (MIT) where he received his Doctor of Philosophy degree in Chemistry.
Dr. Scott Rocklage was very notable during his time at MIT. He was under the mentorship of Richard R. Schrock, a renowned Nobel Peace Prize winner in Chemistry in 2005. Rocklage used to conduct his research at Schrock’s laboratory at the esteemed institute.
Dr. Scott Rocklage Career
Dr. Scott Rocklage has been a managing partner at 5AM Ventures since 2004. He joined the company in 2003 as a venture partner and quickly moved up the ranks thanks to his experience and reputation.
Under his leadership, 5AM Ventures has risen up the ranks to become one of the biggest companies in its niche with several patents under its belt.
Dr. Scott Rocklage has worked for several companies since the start of his career. He was the chairman and Chief Operating Officer at Cubist Pharmaceuticals before joining 5AM Ventures. Before that he was the CEO of Nycomed Salutar where he also held several Research and Design (R&D) positions.
He has also served as the Chairman of Board at Novra Therapeutics, Inc. as well as the Chairman of Board at Cidara Therapeutics, Inc. Other positions that he has held include the CEO and President of Amercham Health as well as the Executive Chairman and Co-President at Ilypsa, Inc.
A Progressive Leader
Several factors combine to make Dr. Scott Rocklage one of the most progressive leaders in the healthcare industry. To start with, he has over three decades of experience working in different companies and in varying positions mostly revolving around leadership.
Additionally, he places great emphasis on working with the best professionals in his niche as is evident in the team of employees at 5AM Ventures.
Dr. Scott Rocklage has been so successful that he has managed to get FDA approval for three new drugs: Cubicin, Omniscan, and Teslascan.
Read more: Scott Racklage | Bloomberg